Shape analysis of subcortical nuclei in Huntington's disease, global versus local atrophy — Results from the TRACK-HD study
暂无分享,去创建一个
Simon J. A. van den Bogaard | L. Ferrarini | L. Ferrarini | J. Milles | R. Roos | J. Grond | E. Dumas | M. A. van Buchem | J. van der Grond | R.A.C. Roos | S.J.A. van den Bogaard | E. M. Dumas | J. Milles | M. Buchem | E. Dumas | J. V. D. Grond | R. A. C. Roos | R. Roos
[1] I. Veer,et al. Strongly reduced volumes of putamen and thalamus in Alzheimer's disease: an MRI study , 2008, Brain : a journal of neurology.
[2] Nick C Fox,et al. Pitfalls in the Use of Voxel-Based Morphometry as a Biomarker: Examples from Huntington Disease , 2010, American Journal of Neuroradiology.
[3] Fred L. Bookstein,et al. “Voxel-Based Morphometry” Should Not Be Used with Imperfectly Registered Images , 2001, NeuroImage.
[4] Jan Kassubek,et al. Thalamic atrophy in Huntington's disease co-varies with cognitive performance: a morphometric MRI analysis. , 2005, Cerebral cortex.
[5] J Kassubek,et al. Topography of cerebral atrophy in early Huntington’s disease: a voxel based morphometric MRI study , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[6] Jeroen van der Grond,et al. Early changes in white matter pathways of the sensorimotor cortex in premanifest Huntington's disease , 2012, Human brain mapping.
[7] Mark A. van Buchem,et al. GAMEs: Growing and adaptive meshes for fully automatic shape modeling and analysis , 2007, Medical Image Anal..
[8] Jane S. Paulsen,et al. CAG‐repeat length and the age of onset in Huntington disease (HD): A review and validation study of statistical approaches , 2010, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[9] Jeroen van der Grond,et al. Early atrophy of pallidum and accumbens nucleus in Huntington’s disease , 2010, Journal of Neurology.
[10] S. Haber,et al. The cortico-basal ganglia integrative network: The role of the thalamus , 2009, Brain Research Bulletin.
[11] R. Roos,et al. Neuronal distribution in the putamen in Huntington's disease. , 1985, Journal of neurology, neurosurgery, and psychiatry.
[12] G. Egan,et al. Magnetic resonance imaging as an approach towards identifying neuropathological biomarkers for Huntington's disease , 2008, Brain Research Reviews.
[13] Johan H. C. Reiber,et al. MMSE scores correlate with local ventricular enlargement in the spectrum from cognitively normal to Alzheimer disease , 2008, NeuroImage.
[14] Martin Styner,et al. A comparison of automated segmentation and manual tracing for quantifying hippocampal and amygdala volumes , 2009, NeuroImage.
[15] E. Vandenbussche,et al. Cognitive changes in patients with Huntington’s disease (HD) and asymptomatic carriers of the HD mutation , 2004, Journal of Neurology.
[16] S B Dunnett,et al. Abnormal Synaptic Plasticity and Impaired Spatial Cognition in Mice Transgenic for Exon 1 of the Human Huntington's Disease Mutation , 2000, The Journal of Neuroscience.
[17] J. Reiber,et al. Ventricular shape biomarkers for Alzheimer's disease in clinical MR images , 2008, Magnetic resonance in medicine.
[18] Stephen M. Smith,et al. Bayesian statistical models of shape and appearance for subcortical brain segmentation , 2007 .
[19] M. MacDonald,et al. CAG repeat number governs the development rate of pathology in Huntington's disease , 1997, Annals of neurology.
[20] Richard S. J. Frackowiak,et al. Evidence for Segregated and Integrative Connectivity Patterns in the Human Basal Ganglia , 2008, The Journal of Neuroscience.
[21] G. Frisoni,et al. How fast will it go, doc? , 2008, Neurology.
[22] H. Heinsen,et al. Nerve cell loss in the thalamic mediodorsal nucleus in Huntington’s disease , 1999, Acta Neuropathologica.
[23] Natalie L. M. Cappaert,et al. The anatomy of memory: an interactive overview of the parahippocampal–hippocampal network , 2009, Nature Reviews Neuroscience.
[24] R. Ferrante,et al. Neuropathological Classification of Huntington's Disease , 1985, Journal of neuropathology and experimental neurology.
[25] Wilhelm Gaus,et al. Evidence for more widespread cerebral pathology in early HD: An MRI-based morphometric analysis , 2004, Neurology.
[26] Nick C Fox,et al. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data , 2009, The Lancet Neurology.
[27] Jane S. Paulsen,et al. A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length , 2004, Clinical genetics.
[28] Gregory McCarthy,et al. Scan–rescan reliability of subcortical brain volumes derived from automated segmentation , 2010, Human brain mapping.
[29] N. Swindale,et al. Diffusion tensor fiber tracking shows distinct corticostriatal circuits in humans , 2004, Annals of neurology.
[30] Karl J. Friston,et al. Voxel-Based Morphometry , 2015 .
[31] Jane S. Paulsen,et al. Detection of Huntington’s disease decades before diagnosis: the Predict-HD study , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.
[32] Elizabeth H. Aylward,et al. Change in MRI striatal volumes as a biomarker in preclinical Huntington's disease , 2007, Brain Research Bulletin.